美国疾控中心疫苗咨询小组推迟了2026年3月的会议, 讨论领导力、法律问题和失去信任等问题。 U.S. CDC’s vaccine advisory panel delays March 2026 meeting over leadership, legal issues, and loss of trust.

美国疾病防治中心免疫做法咨询委员会(ACIP)由于法律和领导问题,包括错过了公告截止日期和卫生署领导层的变动,推迟了2026年3月的会议。 The U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) is postponing its March 2026 meeting due to legal and leadership issues, including missed public notice deadlines and changes in HHS leadership. 推迟的原因是美国妇产科医生学会决定退出对透明度和代表性的关切的小组。 The delay follows the American College of Obstetricians & Gynecologists’ decision to withdraw from the panel over concerns about transparency and representation. 该委员会负责制定国家疫苗政策,在一次重大改组后面临混乱,这次改组取代了其成员,使一些专家不再担任关键角色。 The committee, which shapes national vaccine policies, has faced disruptions after a major restructuring that replaced its membership and removed some experts from key roles. 法律挑战和政治压力进一步使其业务复杂化,使人们对更新疫苗接种准则方面的拖延以及破坏对循证建议的信任感到关切。 Legal challenges and political pressures have further complicated its operations, raising concerns about delays in updating vaccination guidelines and undermining trust in evidence-based recommendations.